Noteworthy events of the last week…
First up is Barington/Hilco with the announcement they have terminated their LOI with Specialty Brands Holdings. For those that can remember that far back, Barington/Hilco IPO’d on May 5th of 2015 and were supposed to complete a business combination in 21 months. Well, they’re going on three years now after multiple deadline extensions and are now looking at June 30th, 2018 to complete an acquisition. If they can manage to pull off yet another LOI and another extension, they could technically still complete, but realistically, how good of a transaction can they actually bring to the table with so little cash left??
Barington/Hilco still hasn’t filed their 10-K, but as of the most recent 10-Q they had only $14.7 million cash left in trust (after redemptions) and that number will likely get worse after this next round. You can see that public lack of confidence reflected in the price of the warrants which are currently trading at only $0.14….if you’re still holding the common, redeem! redeem! redeem!
Jensyn Acquisition Corp. has the exact same problem. This time however, it was the seller (BAE Energy) that terminated the LOI, but Jensyn is in a slightly better position with $41 million currently held in trust as of their recently released 10-K. Their completion deadline is June 5th, so it is highly likely they will extend.
However, both Barington/Hilco and Jensyn again demonstrate the importance of evaluating SPAC management teams and the underwriters/advisors when choosing to invest. You want an A+ SPAC management team that has solid experience negotiating deals and the ability to tap into deal flow via the banks and advisors. That’s not to say a smaller bank won’t have access to good deals (Leerink is a great example of a specialty boutique focused on the life sciences), but chances are just greater if you have a bulge bracket bank on the cover.
I’m predicting a busy summer of announcements come June and July. There are currently 22 SPACS seeking a target that have less than one year left to complete an acquisition and of those, 11 have less than 7 months. In order to complete by year end (and taking into account the dead month of August) you should see a flurry of annoucements in the next 2-3 months.
You can check all of the completion deadlines by checking the most recently posted weekly update found here.
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...